Overview
- INCA estimates roughly 8,020 new ovarian cancer cases each year in Brazil for 2026 to 2028, signaling a sizable and persistent burden.
- There is no effective screening test for the general population, so many tumors are found at advanced stages and outcomes worsen when diagnosis comes late.
- Doctors flag persistent bloating, pelvic pain or pressure, early fullness after small meals, bowel changes, frequent urination, and unexplained abdominal growth as warning signs that merit evaluation.
- Experts emphasize targeted genetic testing for those with strong family histories and, for select high‑risk patients, preventive surgery that can include removing the fallopian tubes or ovaries.
- As part of the care response, Unimed Cuiabá offers an integrated oncology pathway and a palliative‑care network (JPO and RCC) aligned with ANS and ASCO guidance to support patients through diagnosis and treatment.